Linike Medical Group Ltd (LNMG)
USD 0.13
(13.64%)
USD 0.13
(13.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2018 | 2013 |
|---|---|---|---|---|---|---|
| Revenue | 8.95 Million | - | - | - | - | - |
| Cost of Revenue | 65.11 Thousand | - | - | - | - | 593.00 |
| Gross Profit | 8.88 Million | - | - | - | - | -593.00 |
| Operating Expenses | 7.89 Million | 65.97 Thousand | 29.86 Thousand | 88.56 Thousand | 1075.00 | 214.51 Thousand |
| Selling, General and Administrative Expenses | 7.89 Million | 65.97 Thousand | 29.86 Thousand | 88.56 Thousand | 1075.00 | 214.51 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 7.96 Million | 65.97 Thousand | 29.86 Thousand | 88.56 Thousand | 1075.00 | 215.1 Thousand |
| Operating Income | 991.04 Thousand | -65.98 Thousand | -29.86 Thousand | -88.57 Thousand | -1080.00 | -215.1 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.00 | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | - | -3.00 |
| Earnings before Tax | 991.04 Thousand | -65.97 Thousand | -29.86 Thousand | -88.56 Thousand | -1075.00 | -427.76 Thousand |
| Net Income | 991.04 Thousand | -65.97 Thousand | -29.86 Thousand | -88.56 Thousand | -1075.00 | -427.76 Thousand |
| Earnings Per Share Basic | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.25 |
| Earnings Per Share Diluted | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.25 |
| Weighted Average Shares Outstanding | 668.94 Million | 635.4 Million | 509.47 Million | 96.92 Million | 3.47 Million | 1.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 668.94 Million | 635.4 Million | 509.47 Million | 96.92 Million | 3.47 Million | 1.73 Million |
| Gross Margin | 0.99 | - | - | - | - | - |
| EBIT Margin | 0.12 | - | - | - | - | - |
| Profit Margin | 0.11 | - | - | - | - | - |
| EBITDA | 1.05 Million | -65.98 Thousand | -29.86 Thousand | -88.57 Thousand | -1080.00 | -214.51 Thousand |
| Earnings Before Tax Margin | 0.11 | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.48 Million | 1.36 Million | 4.61 Million | 8.95 Million | 2.09 Million | 1.84 Million |
| Cost of Revenue | 18.31 Thousand | - | 94.91 Thousand | 65.11 Thousand | 30.95 Thousand | 15.7 Thousand |
| Gross Profit | 3.46 Million | 1.36 Million | 4.52 Million | 8.88 Million | 2.06 Million | 1.83 Million |
| Operating Expenses | 3.94 Million | 2.05 Million | 3.81 Million | 7.89 Million | 1.79 Million | 1.61 Million |
| Selling, General and Administrative Expenses | 3.94 Million | 2.05 Million | 3.81 Million | - | 1.79 Million | 1.61 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.96 Million | 2.05 Million | 3.9 Million | 7.96 Million | 1.82 Million | 1.63 Million |
| Operating Income | -480.89 Thousand | -694.55 Thousand | 711.64 Thousand | 991.04 Thousand | 266.96 Thousand | 211.89 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -3.00 | - | -4.00 | -1.00 | - | 1.00 |
| Earnings before Tax | -480.89 Thousand | -694.55 Thousand | 711.64 Thousand | 991.04 Thousand | 266.96 Thousand | 211.88 Thousand |
| Net Income | -480.89 Thousand | -694.55 Thousand | 711.64 Thousand | 991.04 Thousand | 266.96 Thousand | 211.88 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | 0.00 | - | 0.00 | 0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | 0.00 | - | 0.00 | 0.00 |
| Weighted Average Shares Outstanding | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million | 668.94 Million |
| Gross Margin | 0.99 | 1.00 | 0.98 | 0.99 | 0.99 | 0.99 |
| EBIT Margin | -0.13 | -0.56 | 0.17 | - | 0.14 | 0.12 |
| Profit Margin | -0.14 | -0.51 | 0.15 | 0.11 | 0.13 | 0.11 |
| EBITDA | -462.58 Thousand | -764.24 Thousand | 806.55 Thousand | - | 297.91 Thousand | 227.6 Thousand |
| Earnings Before Tax Margin | -0.14 | -0.51 | 0.15 | 0.11 | 0.13 | 0.11 |
2337
FFLO
IDA
MEDICAPQ
9325
VS